GLP-1 Weight Loss Drugs in 2026: Benefits, Costs, and Access Challenges
GLP-1 weight loss drugs are transforming obesity care—but their high cost raises urgent questions about access, insurance coverage, and long-term sustainability.
obesity management
Mounjaro vs. Zepbound: Same Drug, Different Missions in Diabetes and Weight Loss
Mounjaro and Zepbound contain the same drug—tirzepatide—but serve different purposes. Here’s how they compare in weight loss, diabetes control, and cost.